Loading clinical trials...
Loading clinical trials...
A Randomized, Multi-center, Parallel Group, Double Blind, Placebo and Formoterol Controlled 14 Day Dose Ranging Trial of 4 Doses of Indacaterol Delivered Via TWISTHALER® Device in Adult and Adolescent Patients With Persistent Asthma
Conditions
Interventions
indacaterol
formoterol
+3 more
Locations
60
Belgium
Novartis Investigator Site
Aalst, Belgium
Novartis Investigator Site
Halen, Belgium
Novartis Investigator Site
Oostham, Belgium
Novartis Investigator site
Veurne, Belgium
Novartis Investigator Site
Boskovice, Czechia
Novartis Investigator Site
Brno, Czechia
Start Date
October 1, 2007
Primary Completion Date
April 1, 2008
Completion Date
April 1, 2008
Last Updated
January 18, 2013
NCT02327897
NCT07219173
NCT07486401
NCT04706988
NCT04639791
NCT06471257
Lead Sponsor
Novartis Pharmaceuticals
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions